- Home
- ICCM vs ICMB Comparison
ICCM vs ICMB Comparison
Compare ICCM & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | ICCM | ICMB |
|---|---|---|
| Founded | 2006 | 2012 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Finance: Consumer Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.5M | 40.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ICCM | ICMB |
|---|---|---|
| Price | $0.68 | $2.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 403.0K | 42.8K |
| Earning Date | 11-19-2025 | 11-12-2025 |
| Dividend Yield | N/A | ★ 18.25% |
| EPS Growth | N/A | ★ 31.51 |
| EPS | N/A | ★ 0.38 |
| Revenue | $2,975,000.00 | ★ $17,931,778.00 |
| Revenue This Year | $13.67 | N/A |
| Revenue Next Year | $38.55 | $4.75 |
| P/E Ratio | ★ N/A | $7.43 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.59 | $2.46 |
| 52 Week High | $1.66 | $3.47 |
Technical Indicators
Market Signals| Indicator | ICCM | ICMB |
|---|---|---|
| Relative Strength Index (RSI) | 40.13 | 46.92 |
| Support Level | $0.67 | $2.83 |
| Resistance Level | $0.73 | $2.90 |
| Average True Range (ATR) | 0.04 | 0.10 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 56.00 | 19.17 |
Price Performance
Historical ComparisonAbout ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.